ArticleCell death & disease2011

Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells.

M Michaelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.